Plain-English translation of NCT06896370 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study—meaning researchers will follow people over time rather than give them a new treatment. Researchers want to understand why some people who carry H. pylori (a common stomach bacteria) develop stomach cancer while others don't. The study will compare people with different genetic variations of the bacteria to see if certain types are more dangerous.
Stomach cancer is a serious disease, and H. pylori infection is a known risk factor. However, not everyone with this infection develops cancer. By studying people with different types of the bacteria, researchers hope to identify who is at highest risk and potentially prevent cancer before it starts.
You likely qualify if…
You likely don't qualify if…
You would have baseline tests and examinations to check your stomach health and identify your H. pylori type. Then, researchers would follow you over time with regular check-ups to monitor whether you develop stomach cancer or precancerous changes. The study involves 3,000 participants and focuses on tracking your health through examinations and possibly endoscopy or other standard stomach screening tests.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China
Enrollment target
~3,000 participants
Started
July 2025
Primary completion
May 2035
Age range
40 Years and older
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Dazhi Xu, PhD
Fudan University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.